Viewing Study NCT02027493


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-01-04 @ 5:55 AM
Study NCT ID: NCT02027493
Status: COMPLETED
Last Update Posted: 2014-01-06
First Post: 2014-01-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV
Sponsor: National Liver Institute, Egypt
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NLI-YAGCC-CUPH-HCV-PEG-PED
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View